These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33760252)

  • 1. A simple alternative and improved HPLC method for the estimation of doravirine, lamivudine, and tenofovir disoproxil fumarate in solid oral dosage form.
    Kokkirala TK; Kancherla P; Alegete P; Suryakala D
    Biomed Chromatogr; 2021 Aug; 35(8):e5121. PubMed ID: 33760252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple stability indicating RP-HPLC-DAD method for concurrent analysis of Tenofovir Disoproxil Fumarate, Doravirine and Lamivudine in pure blend and their combined film coated tablets.
    Godela R; Gummadi S
    Ann Pharm Fr; 2021 Nov; 79(6):640-651. PubMed ID: 34019910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Bioavailability of Oral Granule Formulations of the HIV Antiretroviral Drugs Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate.
    Yee KL; DiBenedetto A; Fan L; Khalilieh S; Triantafyllou I; Vallee MH; Fackler P; Stoch SA; Iwamoto M
    AAPS PharmSciTech; 2020 Feb; 21(3):91. PubMed ID: 32060665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and efficient chiral method development for lamivudine and tenofovir disoproxil fumarate fixed dose combination using ultra-high performance supercritical fluid chromatography: A design of experiment approach.
    Kurmi M; Jayaraman K; Natarajan S; Kumar GS; Bhutani H; Bajpai L
    J Chromatogr A; 2020 Aug; 1625():461257. PubMed ID: 32709317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RP-HPLC method for simultaneous estimation of tenofovir disoproxil fumarate, lamivudine, and efavirenz in combined tablet dosage form.
    Bhavsar DS; Patel BN; Patel CN
    Pharm Methods; 2012 Jul; 3(2):73-8. PubMed ID: 23781482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial.
    Molina JM; Yazdanpanah Y; Afani Saud A; Bettacchi C; Chahin Anania C; DeJesus E; Olsen Klopfer S; Grandhi A; Eves K; Robertson MN; Correll T; Hwang C; Hanna GJ; Sklar P
    Lancet HIV; 2021 Jun; 8(6):e324-e333. PubMed ID: 34000227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple thin layer chromatography-ultraviolet spectrophotometric method for quality assessment of binary fixed-dose-combinations of lamivudine/tenofovir disoproxil fumarate and lamivudine/zidovudine in tablet formulations.
    Vaikosen EN; Kashimawo AJ; Soyinka JO; Orubu S; Elei S; Ebeshi BU
    J Sep Sci; 2020 Jun; 43(11):2228-2239. PubMed ID: 32125772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014.
    Melvin AJ; Yee KL; Gray KP; Yedla M; Wan H; Tobin NH; Teppler H; Campbell H; McCarthy K; Scheckter R; Aurpibul L; Ounchanum P; Rungmaitree S; Cassim H; McFarland E; Flynn P; Cooper E; Krotje C; Townley E; Moye J; Best BM;
    J Acquir Immune Defic Syndr; 2023 Feb; 92(2):153-161. PubMed ID: 36215957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Validated Stability Indicating RP-HPLC Method for the Determination of Emtricitabine, Tenofovir Disoproxil Fumarate, Elvitegravir and Cobicistat in Pharmaceutical Dosage Form.
    Runja C; Kumar PR; Avanapu SR
    J Chromatogr Sci; 2016; 54(5):759-64. PubMed ID: 26865655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability behaviour of antiretroviral drugs and their combinations. 2: Characterization of interaction products of lamivudine and tenofovir disoproxil fumarate by mass and NMR spectrometry.
    Kurmi M; Kushwah BS; Sahu A; Narayanam M; Singh S
    J Pharm Biomed Anal; 2016 Jun; 125():245-59. PubMed ID: 27042808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetic and Pharmacodynamic Analysis To Evaluate a Switch to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in People Living with HIV-1.
    Vaddady P; Kandala B; Yee KL
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32868326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of ultra performance liquid chromatography-tandem mass spectrometry method for the simultaneous estimation of dolutegravir, lamivudine and tenofovir in bulk and tablet dosage form.
    Veerareddy V; Dodda S; Gangarapu K
    Eur J Mass Spectrom (Chichester); 2021 Dec; 27(6):249-255. PubMed ID: 34851199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doravirine exposure and HIV-1 suppression after switching from an efavirenz-based regimen to doravirine/lamivudine/tenofovir disoproxil fumarate.
    Greaves W; Wan H; Yee KL; Kandala B; Vaddady P; Hwang C
    Antimicrob Agents Chemother; 2019 Sep; 63(12):. PubMed ID: 31548188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Validation of a Simple, Robust, Stability-Indicating RP-HPLC Method for the Simultaneous Detection of Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir Sodium in Bulk Material and Pharmaceutical Formulations.
    Omoteso OA; Milne M; Aucamp M
    Int J Anal Chem; 2022; 2022():3510277. PubMed ID: 35154325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of enantiomeric impurity of tenofovir disoproxil fumarate on a cellulose tris(3,5-dichlorophenyl-carbamate) chiral stationary phase and the characterization of its related substances.
    Nguyen BT; Le TA; Mai XL; Nguyen TNV; Phan TD; Kang JS; Kim KH
    J Sep Sci; 2021 May; 44(10):2029-2036. PubMed ID: 33682357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical method development and validation for simultaneous estimation of Bempedoic acid and Ezetimibe in pure and its pharmaceutical dosage form by RP-HPLC.
    Suresh A; Balakrishnan A; Ramaswamy V; Natesan S
    Biomed Chromatogr; 2024 Sep; 38(9):e5938. PubMed ID: 38922950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of UV-spectrophotometric methods for estimation of tenofovir disoproxil fumarate in tablets.
    A SA; H BC; J SS
    Pak J Pharm Sci; 2009 Jan; 22(1):27-9. PubMed ID: 19168416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doravirine: First Global Approval.
    Deeks ED
    Drugs; 2018 Oct; 78(15):1643-1650. PubMed ID: 30341683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability-Indicating HPLC Method for the Simultaneous Determination of HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate, and Rilpivirine Hydrochloride in Pharmaceutical Dosage Forms.
    Venkatesan S; Kannappan N; Mannemala SS
    Int Sch Res Notices; 2014; 2014():849149. PubMed ID: 27437485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MS.
    Waitt C; Diliiy Penchala S; Olagunju A; Amara A; Else L; Lamorde M; Khoo S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():300-307. PubMed ID: 28651173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.